These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23421352)

  • 1. Effects of a 10-day oxytocin trial in older adults on health and well-being.
    Barraza JA; Grewal NS; Ropacki S; Perez P; Gonzalez A; Zak PJ
    Exp Clin Psychopharmacol; 2013 Apr; 21(2):85-92. PubMed ID: 23421352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal oxytocin administration attenuates the ACTH stress response in monkeys.
    Parker KJ; Buckmaster CL; Schatzberg AF; Lyons DM
    Psychoneuroendocrinology; 2005 Oct; 30(9):924-9. PubMed ID: 15946803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxytocin administration alters HPA reactivity in the context of parent-infant interaction.
    Weisman O; Zagoory-Sharon O; Feldman R
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1724-31. PubMed ID: 23906646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term oxytocin administration enhances the experience of attachment.
    Bernaerts S; Prinsen J; Berra E; Bosmans G; Steyaert J; Alaerts K
    Psychoneuroendocrinology; 2017 Apr; 78():1-9. PubMed ID: 28131072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal oxytocin administration is reflected in human saliva.
    Weisman O; Zagoory-Sharon O; Feldman R
    Psychoneuroendocrinology; 2012 Sep; 37(9):1582-6. PubMed ID: 22436536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The acute effects of intranasal oxytocin administration on endocrine and sexual function in males.
    Burri A; Heinrichs M; Schedlowski M; Kruger TH
    Psychoneuroendocrinology; 2008 Jun; 33(5):591-600. PubMed ID: 18375074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin and psychotherapy: a pilot study of its physiological, behavioral and subjective effects in males with depression.
    MacDonald K; MacDonald TM; Brüne M; Lamb K; Wilson MP; Golshan S; Feifel D
    Psychoneuroendocrinology; 2013 Dec; 38(12):2831-43. PubMed ID: 23810433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
    Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
    Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: a randomized trial.
    Watanabe T; Abe O; Kuwabara H; Yahata N; Takano Y; Iwashiro N; Natsubori T; Aoki Y; Takao H; Kawakubo Y; Kamio Y; Kato N; Miyashita Y; Kasai K; Yamasue H
    JAMA Psychiatry; 2014 Feb; 71(2):166-75. PubMed ID: 24352377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensitivity to intranasal oxytocin in adult men with early parental separation.
    Meinlschmidt G; Heim C
    Biol Psychiatry; 2007 May; 61(9):1109-11. PubMed ID: 17141739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose oxytocin delivered intranasally with Breath Powered device affects social-cognitive behavior: a randomized four-way crossover trial with nasal cavity dimension assessment.
    Quintana DS; Westlye LT; Rustan ØG; Tesli N; Poppy CL; Smevik H; Tesli M; Røine M; Mahmoud RA; Smerud KT; Djupesland PG; Andreassen OA
    Transl Psychiatry; 2015 Jul; 5(7):e602. PubMed ID: 26171983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and tolerability of chronic intranasal oxytocin in older men: results from a randomized controlled trial.
    Rung JM; Horta M; Tammi EM; Perez E; Ojeda MC; Lin T; Harris G; Somerville J; Salmeron D; Beltz SE; Sandesara B; Feifel D; Ebner NC
    Psychopharmacology (Berl); 2021 Sep; 238(9):2405-2418. PubMed ID: 33982141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal oxytocin modulates EEG mu/alpha and beta rhythms during perception of biological motion.
    Perry A; Bentin S; Shalev I; Israel S; Uzefovsky F; Bar-On D; Ebstein RP
    Psychoneuroendocrinology; 2010 Nov; 35(10):1446-53. PubMed ID: 20493637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining oxytocin administration and positive emotion inductions: Examining social perception and analytical performance.
    Human LJ; Thorson KR; Woolley JD; Mendes WB
    Horm Behav; 2017 Apr; 90():120-128. PubMed ID: 28324706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term administration of intranasal oxytocin is a safe and promising therapy for early adolescent boys with autism spectrum disorders.
    Tachibana M; Kagitani-Shimono K; Mohri I; Yamamoto T; Sanefuji W; Nakamura A; Oishi M; Kimura T; Onaka T; Ozono K; Taniike M
    J Child Adolesc Psychopharmacol; 2013 Mar; 23(2):123-7. PubMed ID: 23480321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonverbal communication of patients with borderline personality disorder during clinical interviews: a double-blind placebo-controlled study using intranasal oxytocin.
    Brüne M; Kolb M; Ebert A; Roser P; Edel MA
    J Nerv Ment Dis; 2015 Feb; 203(2):107-11. PubMed ID: 25594788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal oxytocin administration prior to exposure therapy for arachnophobia impedes treatment response.
    Acheson DT; Feifel D; Kamenski M; Mckinney R; Risbrough VB
    Depress Anxiety; 2015 Jun; 32(6):400-7. PubMed ID: 25826649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.
    Lee MR; Wehring HJ; McMahon RP; Liu F; Linthicum J; Verbalis JG; Buchanan RW; Strauss GP; Rubin LH; Kelly DL
    Schizophr Res; 2016 Apr; 172(1-3):165-8. PubMed ID: 26879587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized controlled trial of intranasal oxytocin as an adjunct to exposure therapy for social anxiety disorder.
    Guastella AJ; Howard AL; Dadds MR; Mitchell P; Carson DS
    Psychoneuroendocrinology; 2009 Jul; 34(6):917-23. PubMed ID: 19246160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary Oxytocin Concentrations in Males following Intranasal Administration of Oxytocin: A Double-Blind, Cross-Over Study.
    Daughters K; Manstead AS; Hubble K; Rees A; Thapar A; van Goozen SH
    PLoS One; 2015; 10(12):e0145104. PubMed ID: 26669935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.